Develops drugs for opioid addiction.
Jun 2026Revenue $1.33B/yrExpenses $911M/yr
Reached break-even Oct 2024
Figures by year
When did Indivior Pharmaceuticals become profitable?
Its revenue passed its expenses in Oct 2024. In the 12 months to Jun 2026, revenue was $1.33B and expenses $911M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $1.24B | $977M | $262M |
| Dec 2024 | $1.19B | $1.15B | $38.0M |
| Dec 2023 | $1.09B | $1.25B | −$152M |
| Dec 2022 | $901M | $982M | −$81.0M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.